Hepatology: The end of the first five‐ year cycle
Irwin M. Arias – 1 November 1985
Hepatitis B. the virus, the disease, and the vaccine. Edited by Irving Millman, Toby K. Eisenstein, and Baruch S. Blumberg, 251 pp. + xi. New York and London: Plenum Press, 1984. $39.50
Charles S. Davidson, Anastacio M. Hoyumpa – 1 November 1985
Antihepatocyte antibodies
Ian G. McFarlane, Roger Williams, U. Hopf, B. Möller, H. C. Thomas – 1 November 1985
On the pathogenesis of focal nodular hyperplasia of the liver
Ian R. Wanless, Carolyn Mawdsley, Ronald Adams – 1 November 1985 – Fifty‐one focal nodular hyperplasia lesions from 36 patients were examined histologically. Serial sections and three‐dimensional models were studied in selected cases. Lesions were multiple in 19% of patients. Thirty‐four patients were female. One case had 11 focal nodular hyperplasia lesions and 7 hemangiomata in the liver. Three had astrocytoma and one had anomalous pulmonary venous drainage.
Notices
1 November 1985
Controversies in immunization against hepatitis B
Arie J. Zuckerman – 1 November 1985
A randomized study of the effects of adenine arabinoside 5′‐monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication
Anna S. F. Lok, David M. Novick, Peter Karayiannis, Arthur A. Dunk, Sheila Sherlock, Howard C. Thomas – 1 November 1985 – A previous randomized controlled study has shown a 30% rate of HBe antigen/antibody serocon‐version within 1 year of a month course of adenine arabinoside‐5′‐monophosphate; no seroconversion occurred in the control group.
Hepatic ontogenesis
Charles E. Cornelius – 1 November 1985
Liver biopsy diagnoses and reports, SNOMED codes, ICD‐9‐CM codes, nomenclature and terminology. By Jurgen Ludwig. 156 pp. Basal: Karger, 1984. $34.75
Michael J. O'Brien, Leonard S. Gottlieb – 1 November 1985
Hepatitis B vaccine: Low postvaccination immunity in hospital personnel given gluteal injections
Karen L. Lindsay, David A. Herbert, Gary L. Gitnick – 1 November 1985 – Although other investigators have found excellent response rates to the hepatitis B vaccine, we report here an unusually low rate of seroconversion following hepatitis B vaccination in a group of apparently healthy medical center personnel. Only 67% of these individuals developed adequate postvaccination antibodies to HBsAg, in contrast to 85 to 96% in other studies.